UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| | |
Date of Report (Date of Earliest Event Reported): | | May 14, 2007 |
VIASPACE Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| | |
Nevada | 333-110680 | 76-0742386 |
_____________________ (State or other jurisdiction | _____________ (Commission | ______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
| | |
171 North Altadena Drive, Suite 101, Pasadena, California | | 91107 |
_________________________________ (Address of principal executive offices) | | ___________ (Zip Code) |
| | |
Registrant’s telephone number, including area code: | | 626-768-3360 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On May 14, 2007, the Company announced that its Ionfinity subsidiary has been granted a patent for a soft ionization membrane. Ionfinity, a subsidiary in which VIASPACE holds a 46.3% membership interest, is working to develop the next-generation mass spectrometry (MS) technology, which could not only revolutionize the traditional applications of MS for industrial process control and environmental monitoring, but could also ring in a new era of detection systems for homeland security. The technology combines two inventions made at NASA Jet Propulsion Laboratory, which should enable the system to provide a 10x increase in sensitivity, a 10x increase in mass range and the ability to miniaturize the product to make it portable and low cost.
A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits
Exhibit No. Description
99.1 Press Release dated May 14, 2007
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| | VIASPACE Inc. |
| | | | |
May 14, 2007 | | By: | | Stephen J. Muzi
|
| | | |
|
| | | | Name: Stephen J. Muzi |
| | | | Title: Chief Financial Officer |
Exhibit Index
| | |
Exhibit No. | | Description |
| |
|
99.1 | | Press Release Dated May 14, 2007 |